A significant reduction in risk of recurrent heart attacks, strokes, and cardiovascular death was found among people who received a targeted anti-inflammatory drug that lowered inflammation but had no effects on cholesterol, ...
Aug 28, 2017
0
10
A major international study has found that the combination of two drugs - rivaroxaban and aspirin—is superior to aspirin alone in preventing further heart complications in people with vascular disease.
Aug 28, 2017
0
2
Women at high risk of cardiovascular events are less likely to receive recommended statin doses for secondary prevention, according to results from the DYSIS study presented today at ESC Congress.
Aug 27, 2017
0
0
An updated analysis of the low-density lipoprotein cholesterol (LDL-C) lowering drugs, proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, finds they are not cost-effective at current prices and that even greater ...
Aug 22, 2017
0
0
(HealthDay)—Five years after coronary-artery bypass grafting (CABG) surgery, patients whose operation was performed with cardiopulmonary bypass (on pump) lived longer than those whose surgeons performed the procedure without ...
Aug 18, 2017
0
0
In a new study published in the journal Circulation, Northwestern Medicine investigators identified similarities and differences between cardiovascular data pulled from electronic health records (EHRs) and data collected ...
Aug 4, 2017
0
1
Compared to people who are of normal weight and metabolically healthy, subjects who are of normal weight but metabolically unhealthy (~20 percent of normal weight adults) have a more than three-fold higher risk of mortality ...
Aug 1, 2017
2
1184
(HealthDay)—For patients with an adverse reaction to a statin, continued statin prescriptions are associated with lower incidence of cardiovascular events and death, according to a study published online July 25 in the ...
Jul 25, 2017
0
0
Statins are known to reduce the risk of death and cardiovascular events for people who are at high risk; however, as many as 75 percent of patients discontinue statin therapy within two years, often after reporting an adverse ...
Jul 24, 2017
0
0
(HealthDay)—For asymptomatic patients with type 2 diabetes, the addition of coronary computed tomography angiography (CCTA)-detected obstructive coronary artery disease (CAD) improves prediction of major adverse cardiovascular ...
Jul 10, 2017
0
0
